Amvis Holdings (7071) cut its net profit forecast for the fiscal year ended Sept. 30, 2026 by 40.5% to ¥1.25 billion from ¥2.1 billion after booking an impairment loss of ¥2.142 billion.
The impairment covers some of the group's Ishinkan facilities. After reviewing the recoverability of fixed assets, the company wrote down facilities with reduced profitability to their recoverable amounts, booking ¥1.636 billion for facilities in western Japan and ¥506 million for those in eastern Japan. The company said the impairment itself involves no new cash outflow.
| Item | Previous forecast | Revised forecast | Change |
|---|---|---|---|
| Sales | ¥51.7 billion | ¥50.0 billion | -3.3% |
| EBITDA | ¥7.1 billion | ¥7.45 billion | +4.9% |
| Operating profit | ¥3.8 billion | ¥4.0 billion | +5.3% |
| Recurring profit | ¥3.3 billion | ¥4.0 billion | +21.2% |
| Net profit | ¥2.1 billion | ¥1.25 billion | -40.5% |
| EPS | ¥21.53 | ¥12.77 | - |
Sales are expected to come in broadly in line with the previous forecast, while operating and recurring profit will exceed it as the comprehensive medical support business expanded more than expected. Net profit falls short due to the impairment. In the prior year, sales were ¥49.174 billion and net profit ¥3.66 billion.
The western Japan impairment relates to facilities in a business being sold under a plan announced Sept. 28, 2026. Amvis will transfer its Ishinkan business covering 47 facilities, mainly in western Japan, to two wholly owned subsidiaries via a company split and sell all shares of both to NSSK-Altair1. It expects to book a gain on the sale of about ¥7.9 billion in the first quarter of the fiscal year ending September 2027. The estimate reflects the impairment and is not included in the revised forecast.
An extraordinary shareholders' meeting is scheduled for Nov. 13, 2026, and the sale is set for Nov. 16, subject to approval and other conditions. The fiscal 2027 forecast, including the gain and deconsolidation effects, will be released with earnings on Nov. 13.
| I-ne | |
| Tender offer price | ¥2,248 per share |
| Kadoya Seiyu | |
| Tender offer price | ¥2,655 per share |
| TKP Corporation | |
| Effective date | March 1, 2027 (scheduled) |
| M3, Inc. | |
| Tender offer price | ¥1,619 per share |
| Digital Hearts Holdings | |
| Consolidation ratio | 2,975,211 shares into 1 share |
| Shoei Corporation | |
| Shares transferred | 1.8 million shares |
| TOSE Co., Ltd. | |
| Effective date (scheduled) | Jan. 4, 2027 |
| NSK Ltd. | |
| Share transfer ratio (NSK:NTN) | 1:0.353 |
| M&A / TOB | 20 |
| Guidance | 7 |
| Buybacks | 11 |
| Dividends | 4 |
| Capital | 12 |
| Earnings | 16 |
| People | 3 |
Summaries of public disclosures by Japanese listed companies. Not investment advice; accuracy not guaranteed. Figures and dates in the TDnet originals prevail.
本站內容為日本上市公司公開開示之摘要整理,非投資建議,亦不保證正確。數字與日程以 TDnet 原文為準。
本サイトは日本の上場企業の適時開示を要約したものであり、投資助言ではありません。正確性は保証しません。数値・日程は TDnet の原文が優先します。